OLON

Olon Group is a global leader in the development and production of active pharmaceutical ingredients for CDMO and Generics, a reliable and preferential partner to the pharmaceutical, biotech, and specialty ingredients markets. With a 2021's turnover of 580 Mio$, OLON supplies 300 APIs for the Generic market. Thanks to all the 2.300 employees, and to highly qualified R&D team - more than 300 people - OLON can offer complete integrated packages and services to support the full development of APIs based on strong knowledge in both Chemical and Biological process, all of them under a full cGMP and regulatory coverage - holder of about 160 active US DMFs and 79 granted CoS. Headquartered in Rodano (Milan, Italy), OLON has 11 manufacturing facilities - 8 located in Italy, 1 in Spain, 1 in USA and 1 in India, designed in compliance with the strictest international requirements, and 3 branch offices in Hamburg (Germany), Florham Park, NJ (USA) and Shanghai (China).